❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Immunology ❭ Molecular immunology and vaccine development (Braathen) ❭ In the media ❭

In the media

Blog: Vaksinebloggen

Podcast: Vaksinepodden

 
Scroll to top

Home Dept. of Immunology Molecular immunology and vaccine development (Braathen)

  • Group members
  • Publications
  • In the media
  • Funding

Recent publications

Robertson AH, Wolf AS, Fossum E, Solum G, Bhandari S, Vikse EL, Kjønstad IF, Magnus P, Nygaard UC, Lund-Johansen F, Trogstad L, Mjaaland S (2026)
Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections
Vaccine, 80, 128511 (in press)
DOI 10.1016/j.vaccine.2026.128511, PubMed 41895154

Jore S, Tønnessen R, Grøntvedt CA, Rydland K, Hauge AG, Hungnes O, Kristoffersen AB, Fossum E (2026)
A Retrospective Cross-Sectional Study (2009-2023): Exploring Influenza A(H1N1)pdm09 Antibody Time Series in Humans and Swine and Vaccine Coverage in Two Target Groups
Zoonoses Public Health (in press)
DOI 10.1111/zph.70051, PubMed 41857313

Werninghaus IC, Hinke DM, Katta K, Bogen B, Braathen R (2026)
A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine
J Immunol, 215 (2)
DOI 10.1093/jimmun/vkaf378, PubMed 41764724

More publications

Get in touch

Ranveig Braathen
Institute of Immunology, Rikshospitalet, Oslo University Hospital
Sognsvannsveien 20, Section A2. 2nd. floor, Room:  A3.2006, 0372 Oslo, Norway
Phone: + 47 23 07 35 08, Cell: + 47 99732296, Fax: + 47 23 07 35 10
Email: Ranveig.braathen@medisin.uio.no, Ranveig.braathen@rr-research.no, ranvbr@ous-hf.no

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)